DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
Public ClinicalTrials.gov record NCT00029523. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Clinical Study to Determine the Patient Benefit and Safety of Depocyt (Cytarabine Liposome Injection) for the Treatment of Neoplastic Meningitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to find out how well an experimental drug called DepoCyt works for neoplastic meningitis (cancer that has spread to the tissues around the brain and spinal cord). DepoCyt is a new slow-release form of the cancer drug called ara-C (cytarabine). Cytarabine has been used for many years to treat cancer.
Study identification
- NCT ID
- NCT00029523
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Intrathecal (injected into the spinal fluid) DepoCyt Drug
- Intrathecal methotrexate Drug
- Intrathecal cytarabine (also known as ara-C) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2001 (Type not available)
- Primary completion
- Not listed
- Completion
- Nov 2004 (Type not available)
- Last update posted
- Feb 28, 2007
2001 – 2004
United States locations
- U.S. sites
- 21
- U.S. states
- 18
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Institute | Phoenix | Arizona | 85013 | — |
| Alta Bates Comprehensive Cancer Center | Berkeley | California | 94704 | — |
| University of Southern California, Norris Cancer Center | Los Angeles | California | 90033 | — |
| University of Colorado Hospital, Anschutz Cancer Pavilion | Denver | Colorado | 80010 | — |
| Georgetown University Medical Center Hematology/Oncology | Washington D.C. | District of Columbia | 20007 | — |
| Mayo Clinic, Jacksonville | Jacksonville | Florida | 32224 | — |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | — |
| Emory Clinic, Department of Neurosurgery | Atlanta | Georgia | 30322 | — |
| Straub Clinic and Hospital | Honolulu | Hawaii | 96813 | — |
| Rush Cancer Institute | Chicago | Illinois | 60612 | — |
| Loyola University Medical Center, Dept. of Hematology/Oncology | Maywood | Illinois | 60153 | — |
| Beth Israel Deaconess Medical Center Dept. of Neurology | Boston | Massachusetts | 02215 | — |
| Park Nicollet Institute, Oncology Research Program | Minneapolis | Minnesota | 55416 | — |
| JFK Neuroscience Institute | Edison | New Jersey | 08820 | — |
| Bowman Gray School of Medicine/Comprehensive Cancer Center of Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| Case Western Reserve University Hospital of Cleveland | Cleveland | Ohio | 44106 | — |
| University of Pittsburgh Cancer Institute | Pittsburgh | Pennsylvania | 15213 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| University of Texas Health Science Center | San Antonio | Texas | 78284 | — |
| University of Utah, Hunsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00029523, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2007 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00029523 live on ClinicalTrials.gov.